Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.25965 http://scihub22266oqcxt.onion/10.1002/jmv.25965 32369222!7267323!32369222     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Virol 2020 ; 92 (9): 1484-1490 Nephropedia Template TP {{tp|p=32369222|t=2020. The management of coronavirus disease 2019 (COVID-19) |pdf=|usr=}}{{32369222}} gab.com Text The management of coronavirus disease 2019 (COVID-19) JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32369222 #FOAvip In December 2019, a novel coronavirus causing severe acute respiratory disease occurred in Wuhan, China. It is an emerging infectious disease with widespread and rapid infectiousness. The World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern on 31 January 2020. Severe COVID-19 patients should be managed and treated in a critical care unit. Performing a chest X-ray/CT can judge the severity of the disease. The management of COVID-19 patients includes epidemiological risk and patient isolation; treatment entails general supportive care, respiratory support, symptomatic treatment, nutritional support, psychological intervention, etc. The prognosis of the patients depends upon the severity of the disease, the patient's age, the underlying diseases of the patients, and the patient's overall medical condition. The management of COVID-19 should focus on early diagnosis, immediate isolation, general and optimized supportive care, and infection prevention and control. Twit Text FOAVip The management of coronavirus disease 2019 (COVID-19) ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32369222 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32369222 #FOAvip English Wikipedia <ref>{{Cite pmid|32369222}}</ref> The management of coronavirus disease 2019 (COVID-19) #MMPMID32369222 Liu J; Liu S J Med Virol 2020[Sep]; 92 (9): 1484-1490 PMID32369222show ga In December 2019, a novel coronavirus causing severe acute respiratory disease occurred in Wuhan, China. It is an emerging infectious disease with widespread and rapid infectiousness. The World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern on 31 January 2020. Severe COVID-19 patients should be managed and treated in a critical care unit. Performing a chest X-ray/CT can judge the severity of the disease. The management of COVID-19 patients includes epidemiological risk and patient isolation; treatment entails general supportive care, respiratory support, symptomatic treatment, nutritional support, psychological intervention, etc. The prognosis of the patients depends upon the severity of the disease, the patient's age, the underlying diseases of the patients, and the patient's overall medical condition. The management of COVID-19 should focus on early diagnosis, immediate isolation, general and optimized supportive care, and infection prevention and control. |*Disease Management[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19 Testing[MESH] |COVID-19/*diagnosis/*therapy[MESH] |Comorbidity[MESH] |Humans[MESH] |Pandemics[MESH] |Patient Isolation[MESH] |Prognosis[MESH] |Radiography, Thoracic[MESH] |Respiratory Therapy[MESH] |Risk Factors[MESH]The management of coronavirus disease 2019 (COVID-19) (epmc).pdf DeepDyve Pubget Overpricing